Current role
Biotechnology · Healthcare
Board Member
2022-09-15–present
David Slack
Equibles does not estimate personal net worth.
Get an email with a short summary when Lisata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LSTA alertsAbout David Slack
David Slack is recorded as Board Member at Lisata Therapeutics, Inc. (LSTA) since September 15, 2022. Lisata Therapeutics, Inc. reported in an 8-K filed May 1, 2023 that David Slack resigned as Director, effective May 1, 2023. Lisata Therapeutics, Inc. reported in an 8-K filed May 1, 2023 that David Slack was terminated as President and Chief Business Officer, effective May 1, 2023. Lisata Therapeutics, Inc. reported in an 8-K filed September 15, 2022 that David Slack was appointed President and Chief Business Officer, effective September 15, 2022. Equibles holds 4 filed executive changes naming David Slack; each is listed under recent activity with its source filing. The proxy statement of Lisata Therapeutics, Inc. reports total compensation of $1,213,429 for David Slack in fiscal 2023, including a base salary of $159,745. Disclosed compensation is on record for 3 fiscal years. Lisata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lisata Therapeutics, Inc. includes David J. Mazzo (CEO and Board Member), David J. Mazzo, Ph.D. (CEO), Gregory Brown (Chairman) and 7 others.
“Accordingly, Mr. Slack has effectively resigned from the Company's Board of Directors as of May 1, 2023 pursuant to the terms of his Employment Agreement.”
“On May 1, 2023, Lisata Therapeutics, Inc. (the "Company"), after a careful review of capital utilization and prioritization, eliminated the position of President and Chief Business Officer, and terminated the employment of Mr. David Slack, effective immediately.”
Affiliation history
-
Current
2022-09-15–present
-
Lisata Therapeutics, Inc. (LSTA)
SEC 8-K
Current2022-09-15–present
-
2022-09-15–2023-05-01
-
Lisata Therapeutics, Inc. (LSTA)
Source not stated
Start not stated–2023-05-01
Company network
Leadership on record at Lisata Therapeutics, Inc.
- David J. Mazzo CEO, Board Member
- David J. Mazzo, Ph.D. CEO
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer COO
- Josh Lehrer, M.D., M.Phil., FACC COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
- Anne Whitaker Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Lisata Therapeutics, Inc. (LSTA) | Former President and Chief Business Officer | $159,745 | $1,213,429 |
| 2022 | Lisata Therapeutics, Inc. (LSTA) | Former President and Chief Business Officer | $134,167 | $316,176 |
| 2021 | Lisata Therapeutics, Inc. (LSTA) | Former President and Chief Business Officer | — | — |